Quick Answer
Annovis Bio, Inc. reported Operating Income of -$29.70 million for fiscal year 2025.
Annovis Bio, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$29.70M | -11.2% |
| 2024 | -$26.69M | +40.7% |
| 2023 | -$45.04M | -76.5% |
| 2022 | -$25.51M | -75.5% |
| 2021 | -$14.54M | -118.9% |
| 2020 | -$6.64M | -313.6% |
| 2019 | -$1.61M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.43M | -69.5% | -18.6% |
| June 30, 2025 | -$6.27M | +19.2% | +0.2% |
| March 31, 2025 | -$6.28M | +19.6% | -43.2% |
| September 30, 2024 | -$4.39M | +70.5% | +43.5% |
| June 30, 2024 | -$7.76M | +20.5% | +0.6% |
| March 31, 2024 | -$7.81M | +21.7% | +47.5% |
| September 30, 2023 | -$14.86M | -129.2% | -52.3% |
| June 30, 2023 | -$9.76M | -63.4% | +2.1% |
- Annovis Bio, Inc. showed a decrease of -11.2% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Annovis Bio, Inc.’s operating income has declined by 1749.5% (from -$1.61 million to -$29.70 million).
- The most recent figure is from Annovis Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: